Loading company details...
Beta
Latest Form 4 (Sep 23, 2025): Leonard L. Mazur (Chief Executive Officer): Disposition to Issuer of 125,490 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2025 | Leonard L. Mazur, Chief Executive Officer | Disposition to Issuer | 125,490 | n/a |
| Aug 12, 2025 | Myron Z. Holubiak, Vice Chairman | Disposition to Issuer | 31,373 | n/a |
| Nov 12, 2024 | Carol Webb | Grant/Award | 125,000 | n/a |
| Nov 12, 2024 | Robert Joseph Smith | Grant/Award | 125,000 | n/a |
| Nov 12, 2024 | Jaime Bartushak, Chief Financial Officer | Grant/Award | 350,000 | n/a |
| Nov 12, 2024 | Leonard L. Mazur, Chief Executive Officer | Grant/Award | 600,000 | n/a |
| Nov 12, 2024 | Myron Czuczman, Chief Medical Officer | Grant/Award | 300,000 | n/a |
| Nov 12, 2024 | Suren G. Dutia | Grant/Award | 125,000 | n/a |
| Nov 12, 2024 | Dennis M. Mcgrath | Grant/Award | 125,000 | n/a |
| Nov 12, 2024 | Myron Z. Holubiak, Vice Chairman | Grant/Award | 350,000 | n/a |